ISN Journal editorial selections
Kidney International® Respiratory syncytial virus vaccination induces delayed but robust humoral and cellular immunity in patients receiving hemodialysis Patients receiving hemodialysis are especially vulnerable to respiratory syncytial virus (RSV), but vaccine responses in this group are poorly understood. In a small observational study, the RSV vaccine Arexvy produced robust antibody and cellular immune responses, although antibody levels rose more slowly than...
